173 related articles for article (PubMed ID: 17291233)
1. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy.
van Trappen PO; Rufford BD; Mills TD; Sohaib SA; Webb JA; Sahdev A; Carroll MJ; Britton KE; Reznek RH; Jacobs IJ
Int J Gynecol Cancer; 2007; 17(1):61-7. PubMed ID: 17291233
[TBL] [Abstract][Full Text] [Related]
2. The risk of malignancy index in discrimination of adnexal masses.
Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy index for adnexal masses.
Akdeniz N; Kuyumcuoğlu U; Kale A; Erdemoğlu M; Caca F
Eur J Gynaecol Oncol; 2009; 30(2):178-80. PubMed ID: 19480249
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
[TBL] [Abstract][Full Text] [Related]
7. Risk of malignancy index in the evaluation of patients with adnexal masses.
Clarke SE; Grimshaw R; Rittenberg P; Kieser K; Bentley J
J Obstet Gynaecol Can; 2009 May; 31(5):440-5. PubMed ID: 19604425
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the risk of malignancy index scoring systems (1-4) used in differential diagnosis of adnexal masses.
Ozbay PO; Ekinci T; Caltekin MD; Yilmaz HT; Temur M; Yilmaz O; Uysal S; Demirel E; Kelekci S
Asian Pac J Cancer Prev; 2015; 16(1):345-9. PubMed ID: 25640377
[TBL] [Abstract][Full Text] [Related]
9. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
van den Akker PA; Aalders AL; Snijders MP; Kluivers KB; Samlal RA; Vollebergh JH; Massuger LF
Gynecol Oncol; 2010 Mar; 116(3):384-8. PubMed ID: 19959215
[TBL] [Abstract][Full Text] [Related]
11. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
[TBL] [Abstract][Full Text] [Related]
12. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
[TBL] [Abstract][Full Text] [Related]
13. Performance of the Risk of Malignancy Index for Discriminating Malignant Tumors in Women With Adnexal Masses.
Campos C; Sarian LO; Jales RM; Hartman C; Araújo KG; Pitta D; Yoshida A; Andrade L; Derchain S
J Ultrasound Med; 2016 Jan; 35(1):143-52. PubMed ID: 26657746
[TBL] [Abstract][Full Text] [Related]
14. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses.
Qiu L; Yang F; Luo H
Medicine (Baltimore); 2018 Jul; 97(29):e11536. PubMed ID: 30024542
[TBL] [Abstract][Full Text] [Related]
16. Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay.
Di Legge A; Pollastri P; Mancari R; Ludovisi M; Mascilini F; Franchi D; Jurkovic D; Coccia ME; Timmerman D; Scambia G; Testa A; Valentin L
Ultrasound Obstet Gynecol; 2017 Nov; 50(5):648-656. PubMed ID: 28004457
[TBL] [Abstract][Full Text] [Related]
17. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
Abdulrahman GO; McKnight L; Lutchman Singh K
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
[TBL] [Abstract][Full Text] [Related]
19. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses.
Sohaib SA; Mills TD; Sahdev A; Webb JA; Vantrappen PO; Jacobs IJ; Reznek RH
Clin Radiol; 2005 Mar; 60(3):340-8. PubMed ID: 15710137
[TBL] [Abstract][Full Text] [Related]
20. Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass.
Javdekar R; Maitra N
J Obstet Gynaecol India; 2015 Apr; 65(2):117-21. PubMed ID: 25883443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
